Table 1.
Core characteristics of reviewed studies.
Study | Ages | Total N | Non-ED siblings’ N | Genders | Exclusion of participants with an ED diagnosis | EDs | Design | Control |
---|---|---|---|---|---|---|---|---|
Maloney and Shepard-Spiro (23) | 17–20 | 42 | 21 | Male and Female | No past or present AN diagnosis | AN | Cross sectional | Population norms |
Casper (24) | 17–35 | 63 | 15 | Female | No past or present AN diagnosis | AN | Cross sectional | Healthy controls |
Garley and Johnson (25) | 15–18 | 5 | 5 | Female | No present AN diagnosis | AN | Qualitative | No control group |
Stein et al. (26) | N.A | 367 | 42 | Male and Female | Not excluded | Various | Cohort study | Healthy controls |
Strober et al. (27) | 28a | 905 | 264 | Female | Not excluded | AN, BN | Cohort study | Healthy controls |
Latzer et al., (28) | 11–18 | 9 | 9 | Female | N.A | AN | Qualitative | No control group |
Wunderlich et al. (29) | 12–34 | 252 | 84 | Male and Female | N.A | Various | Cross sectional | Healthy controls |
Benninghoven et al. (30) | 21a | 128 | 38 | Male and Female | N.A | AN, BN | Cross sectional | Healthy controls |
Dimitropoulos et al. (31) | 25a | 12 | 12 | Male and Female | N.A | AN | Qualitative | No control group |
Areemit et al. (32) | 10–18 | 20 | 20 | Male and Female | No past or present ED diagnosis | N.A | Mixed Methods | No control group |
Amianto et al. (33) | 26a | 119 | 31 | Male and Female | No past or present ED diagnosis | AN | Cross sectional | Healthy controls |
Rozenstein et al. (34) | 23a | 95 | 21 | Female | No past or present ED diagnosis | AN, BN | Cross sectional | Healthy controls |
Rozenstein et al. (35) | 23a | 95 | 21 | Female | No past or present ED diagnosis | AN, BN | Cross sectional | Healthy controls |
Dimitropoulos et al. (36) | 14–42 | 52 | 26 | Male and Female | No past or present ED diagnosis | AN | Cross sectional | No control group |
Halvorsen et al. (37) | 13–35 | 67 | 21 | Male and Female | No past or present ED diagnosis | AN | Descriptive | Population norms |
Degortes et al. (38) | 28a | 267 | 32 | Female | No past or present ED diagnosis | AN | Cross sectional | Healthy controls |
Withers et al. (39) | 12–18 | 20 | 20 | Male and Female | N.A | AN | Qualitative | No control group |
Latzer et al. (40) | 13–31 | 60 | 30 | Female | No past or present ED diagnosis | Various | Cross sectional | Healthy controls |
Steinhausen et al. (41) | N.A | 33,185 | 2,854 | N.A | N.A | AN | Cohort study | Healthy controls |
Callio and Gustafsson (42) | 13–20 | 5 | 5 | Male and Female | N.A | N.A | Qualitative | No control group |
Jungbauer et al. (43) | 12–52 | 16 | 16 | Male and Female | N.A | AN | Qualitative | No control group |
Langenberg et al. (44) | 16a | 55 | 55 | Male and Female | N.A | AN | Cross sectional | Population norms |
Yao et al. (45) | N.A | 2,268,786 | N.A | Male and Female | N.A | Various | Cohort study | Healthy controls |
Van Langenberg et al. (46) | 10–18 | 12 | 12 | Male and Female | N.A | AN | Qualitative | No control group |
Fjermestad et al. (47) | 12–23 | 13 | 13 | Male and Female | N.A | AN | Qualitative | No control group |
Weinbach et al. (48) | 15a | 127 | 20 | Female | No present AN diagnosis | AN | Cross sectional | Healthy controls |
N.A, Information not available; aMean age.